A SYSTEMATIC REVIEW OF HEALTH-STATE UTILITY VALUES IN ADVANCED GASTRIC, OESOPHAGEAL, OR GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA

被引:0
|
作者
Carter, Cuyun G. [1 ]
King, D. T. [2 ]
Mitchell, S. A. [2 ]
Hess, L. M. [1 ]
Taipale, K. L. [3 ]
Kiiskinen, U. [3 ]
Rajan, N. [4 ]
Novick, D. [5 ]
Liepa, A. M. [1 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Abacus Int, Bicester, Oxon, England
[3] Oy Eli Lilly Finland Ab, Helsinki, Finland
[4] Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia
[5] Eli Lilly & Co, Windlesham, Surrey, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN141
引用
收藏
页码:A92 / A92
页数:1
相关论文
共 50 条
  • [1] Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review
    Carter, Gebra Cuyun
    King, Denise T.
    Hess, Lisa M.
    Mitchell, Stephen A.
    Taipale, Kaisa-Leena
    Kiiskinen, Urpo
    Rajan, Narayan
    Novick, Diego
    Liepa, Astra M.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (11) : 954 - 966
  • [2] Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
    Young, Kate
    Smyth, Elizabeth
    Chau, Ian
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (06): : 373 - 383
  • [3] Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma
    Connie Kang
    [J]. Targeted Oncology, 2023, 18 (6) : 981 - 989
  • [4] Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma
    Kang, Connie
    [J]. TARGETED ONCOLOGY, 2023, 18 (06) : 981 - 989
  • [5] Modified classification for adenocarcinoma of the gastro-oesophageal junction
    Shearer, Christopher J.
    Going, James J.
    Neilson, Lisa J.
    Stuart, Robert C.
    [J]. ANZ JOURNAL OF SURGERY, 2007, 77 (07) : 544 - 549
  • [6] Gastric or gastro-oesophageal Junction Adenocarcinoma: FLOT improves overall Survival
    Lichert, Frank
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (09): : 1042 - 1042
  • [7] The Role of Nutritional Status in Oesophageal and Gastro-Oesophageal Junction Adenocarcinoma.
    Douglas, R. V.
    Singh, U.
    Sutton, E.
    Williams, A.
    McCaughey, S.
    Kennedy, R.
    Turkington, R. C.
    [J]. BRITISH JOURNAL OF SURGERY, 2019, 106 : 150 - 150
  • [8] Chemotherapy with nivolumab in advanced gastro-oesophageal adenocarcinoma
    Fong, Caroline
    Cunningham, David
    [J]. LANCET, 2021, 398 (10294): : 2 - 3
  • [9] Adenocarcinoma of the gastro-oesophageal junction with a synchronous carcinoid of the duodenum
    McCabe, HL
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (906) : 255 - 256
  • [10] CROSS versus modified MAGIC or FLOT in oesophageal and gastro-oesophageal junction adenocarcinoma
    van Rossum, Peter S. N.
    van Laarhoven, Hanneke W. M.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 959 - 960